GIM
Greylin Investment Management’s United Therapeutics UTHR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | $430K | Sell |
1,350
-75
| -5% | -$23.9K | 0.07% | 62 |
|
2024
Q1 | $327K | Sell |
1,425
-25
| -2% | -$5.74K | 0.05% | 62 |
|
2023
Q4 | $319K | Sell |
1,450
-125
| -8% | -$27.5K | 0.06% | 61 |
|
2023
Q3 | $356K | Hold |
1,575
| – | – | 0.06% | 58 |
|
2023
Q2 | $348K | Sell |
1,575
-400
| -20% | -$88.3K | 0.06% | 57 |
|
2023
Q1 | $442K | Sell |
1,975
-300
| -13% | -$67.2K | 0.08% | 55 |
|
2022
Q4 | $633K | Sell |
2,275
-75
| -3% | -$20.9K | 0.12% | 49 |
|
2022
Q3 | $492K | Sell |
2,350
-50
| -2% | -$10.5K | 0.1% | 51 |
|
2022
Q2 | $566K | Sell |
2,400
-150
| -6% | -$35.4K | 0.11% | 51 |
|
2022
Q1 | $457K | Sell |
2,550
-6,891
| -73% | -$1.23M | 0.08% | 60 |
|
2021
Q4 | $2.04M | Sell |
9,441
-111
| -1% | -$24K | 0.38% | 38 |
|
2021
Q3 | $1.76M | Sell |
9,552
-4,660
| -33% | -$860K | 0.36% | 40 |
|
2021
Q2 | $2.55M | Sell |
14,212
-18,024
| -56% | -$3.23M | 0.49% | 34 |
|
2021
Q1 | $5.39M | Sell |
32,236
-3,588
| -10% | -$600K | 1.12% | 21 |
|
2020
Q4 | $5.44M | Sell |
35,824
-17,365
| -33% | -$2.64M | 1.27% | 17 |
|
2020
Q3 | $5.37M | Sell |
53,189
-61,979
| -54% | -$6.26M | 1.43% | 15 |
|
2020
Q2 | $13.9M | Sell |
115,168
-18,755
| -14% | -$2.27M | 3.93% | 6 |
|
2020
Q1 | $12.7M | Sell |
133,923
-23,293
| -15% | -$2.21M | 3.95% | 5 |
|
2019
Q4 | $13.8M | Sell |
157,216
-20,445
| -12% | -$1.8M | 3.06% | 10 |
|
2019
Q3 | $14.2M | Buy |
177,661
+38,683
| +28% | +$3.08M | 3.38% | 8 |
|
2019
Q2 | $10.8M | Buy |
138,978
+21,200
| +18% | +$1.65M | 2.44% | 11 |
|
2019
Q1 | $13.8M | Sell |
117,778
-3,015
| -2% | -$354K | 3.1% | 9 |
|
2018
Q4 | $13.2M | Buy |
+120,793
| New | +$13.2M | 3.15% | 10 |
|
2018
Q3 | – | Sell |
-118,703
| Closed | -$13.4M | – | 82 |
|
2018
Q2 | $13.4M | Buy |
118,703
+80,006
| +207% | +$9.05M | 2.91% | 9 |
|
2018
Q1 | $4.35M | Buy |
+38,697
| New | +$4.35M | 0.94% | 20 |
|
2017
Q4 | – | Sell |
-3,375
| Closed | -$396K | – | 78 |
|
2017
Q3 | $396K | Buy |
3,375
+400
| +13% | +$46.9K | 0.09% | 60 |
|
2017
Q2 | $386K | Buy |
2,975
+885
| +42% | +$115K | 0.09% | 62 |
|
2017
Q1 | $283K | Buy |
+2,090
| New | +$283K | 0.07% | 70 |
|